Comparison of Two Rapid Latex Agglutination Tests for Detection of Cryptococcal Capsular Polysaccharide
Authors:
Open Access
- 1 May 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 109 (5) , 634-641
Abstract
The Murex Cryptococcus Test was compared with the Cryptococcal Antigen Latex Agglutination System (CALAS) for detecting cryptococcal polysaccharide in 173 cerebrospinal fluid (CSF) specimens and 117 serum samples with 99% and 97% concordance, respectively. Eighteen CSF samples and 17 serum samples were positive in both assays, and 249 were negative. The sensitivity and specificity of the Murex relative to the CALAS were 90% and 100%, respectively, for CSF, and 81% and 100%, respectively, for serum. Six discrepancies were arbitrated by retesting, using a third analytic method, review of other laboratory and clinical data, or both. The reaction in 1 CSF specimen was considered false positive by the CALAS, and the reactions in 2 serum samples were false negatives by the Murex. For 3 patients with previous cryptococcal meningitis but no active disease, only the CALAS detected antigen, suggesting that the Murex has less analytic sensitivity in this context. Titer differences dictate that direct comparisons between the 2 tests are not feasible. There were no false-positive reactions in limited testing with either method using specimens from patients with concurrent noncryptococcal infections or in rheumatoid factor-positive serum samples. Infections caused by Cryptococcus neoformans serotypes A or AD were detected equally by both assays. Based on our study, we have elected to continue to use the CALAS for routine testing for cryptococcal antigen.Keywords
This publication has 15 references indexed in Scilit:
- Measurement of Cryptococcal Antigen in Serum and Cerebrospinal Fluid: Value in the Management of AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1994
- Persistence of initial infection in recurrent Cryptococcus neoformans meningitisThe Lancet, 1993
- Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal MeningitisNew England Journal of Medicine, 1992
- Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigensJournal of Clinical Microbiology, 1991
- Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatmentJournal of Clinical Microbiology, 1991
- Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosisJournal of Clinical Microbiology, 1991
- Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodiesInfection and Immunity, 1989
- Infections withCryptococcus neoformansin the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Cryptococcal Meningitis in Patients with AIDSThe Journal of Infectious Diseases, 1988
- The biochemical basis for the distinction between the two cryptococcus neoformans varieties with CGB mediumZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1986